[Effect of thymalin on the development of experimental hyperlipidemia and atherosclerosis].
Ryzhenkov. V E VE; Ogurtsov. R P RP; Trubacheva. V V VV; Popov. V G VG; Puzyreva. V P VP
Key Findings
- Thymalin reduced plasma lipid levels in cholesterol‑fed rabbits.
- The peptide decreased early atherosclerotic changes in the arteries.
- Thymalin normalized T‑suppressor cell activity and their response to atherogenic lipoproteins.
Practical Outcomes
- The results hint that thymalin might have blood‑lipid‑lowering and anti‑plaque properties, but the evidence is limited to an animal model. For biohackers, there is no human dosage, safety, or efficacy data yet, so it cannot be recommended as a ready‑to‑use supplement for cholesterol or heart health. More research, especially in people, is needed before practical protocols can be designed.
Summary
In a rabbit study, the thymus‑derived peptide thymalin lowered blood fats and reduced early signs of artery plaque when the animals ate a high‑cholesterol diet for three months. It also helped restore normal immune cell function that is usually disturbed by high cholesterol.
Abstract
Thymalin, which is a polypeptide preparation from thymus, exhibited hypolipidemic and antiatherosclerotic actions in rabbits maintained on a cholesterol-containing diet during three months. At the same time, thymalin caused favourable effect on the functional activity of lymphocytes impaired in hyperlipidemic animals, i.e. it normalized the T-suppressor activity and sensitivity to atherogenic lipoproteins.
Study Information
pubmed
1988